According to the current information, using nano gels in the eyes have therapeutic benefits. Industry growth in the pharmaceutical and healthcare sectors has been filled by …
S Li, Z Lu, Y Huang, Y Wang, Q Jin, X Shentu… - Advanced …, 2022 - Wiley Online Library
Dry eye disease (DED) impacts≈ 30% of the world's population and causes serious ocular discomfort and even visual impairment. Inflammation is one core cause of the DED vicious …
G Dalei, S Das - Journal of Drug Delivery Science and Technology, 2022 - Elsevier
Polyacrylic acid (PAA)-based drug carrier systems have garnered much significance towards the delivery of various therapeutic agents via different administration routes for the …
Y Wu, Q Tao, J Xie, L Lu, X Xie, Y Zhang, Y Jin - Gels, 2023 - mdpi.com
Nanotechnology has accelerated the development of the pharmaceutical and medical technology fields, and nanogels for ocular applications have proven to be a promising …
G Fang, Q Wang, X Yang, Y Qian, G Zhang… - Carbohydrate polymers, 2022 - Elsevier
Anterior uveitis is a sight-threatening inflammation inside the eyes. Conventional eye drops for anti-inflammatory therapy need to be administered frequently owing to the rapid …
BN Kumara, R Shambhu, KS Prasad - International Journal of Biological …, 2021 - Elsevier
Most of the people in the world are affected by glaucoma, which leads to irreversible blindness. Several patient friendly treatments are available, nevertheless medications lack …
Dry eye disease (DED) is the most common clinical ocular surface disease. Given its multifactorial etiology, no consensus has been reached on the diagnosis criteria for dry eye …
M Thacker, V Singh, S Basu, S Singh - Experimental Eye Research, 2023 - Elsevier
Dry eye disease (DED) is an emerging health problem affecting millions of individuals every year. The current treatments for DED include lubricating eye drops and anti-inflammatory …
Y Xiang, Z Qiu, Y Ding, M Du, N Gao, H Cao… - Journal of Controlled …, 2024 - Elsevier
Dexamethasone (DEX) has been demonstrated to inhibit the inflammatory corneal neovascularization (CNV). However, the therapeutic efficacy of DEX is limited by the poor …